Aurobindo Pharma Facility Receives ‘Official Action Indicated’ Classification From USFDA
2 months ago•Bloomberg Quint
Pharma shares rally; Suven, Granules, Ajanta, Jubilant surge over 5%
2 months ago•Business Standard
Raining Buybacks: 6 companies announce buybacks post Budget. More to follow?
2 months ago•Economic Times
USFDA scrutiny delays generic drug approvals for major Indian pharma firms
2 months ago•Business Standard
Aurobindo Pharma Ltd spurts 1.18%, rises for third straight session
2 months ago•Business Standard
Aurobindo Pharma board approves share buyback plan worth Rs 750 cr
2 months ago•Business Standard
Aurobindo Pharma board gives nod for ₹750 cr. buyback of 51.37 lakh shares at ₹1,460 each
2 months ago•The Hindu